Association of complement 5 genetic polymorphism with renal allograft outcomes in Korea

Deciphering antibody-mediated rejection: new insights into mechanisms and treatment

(2010) Mark D Stegall et al.   Current Opinion in Organ Transplantation

Eculizumab and Renal Transplantation in a Patient with CAPS

(2010) Bonnie E. Lonze et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Long-Term Efficacy of Eculizumab in a Renal Transplant Patient with Recurrent Atypical Hemolytic-Uremic Syndrome

(2009)   AMERICAN JOURNAL OF TRANSPLANTATION

Dendritic Cell Function in Allostimulation Is Modulated by C5aR Signaling

(2009) Q. Peng et al.   JOURNAL OF IMMUNOLOGY

Expression of Complement Components Differs Between Kidney Allografts from Living and Deceased Donors

(2009) M. Naesens et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

C3a Mediates Epithelial-to-Mesenchymal Transition in Proteinuric Nephropathy

(2009) Z. Tang et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Eculizumab for paroxysmal nocturnal haemoglobinuria

(2009) Charles Parker   LANCET

C3 Polymorphisms and Allograft Outcome in Renal Transplantation

(2009) Mira Varagunam et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Use of Antibody to Complement Protein C5 for Salvage Treatment of Severe Antibody-Mediated Rejection

(2008) J. E. Locke et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Pharmacological targeting of C5a receptors during organ preservation improves kidney graft survival

(2008) A. G. Lewis et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Locally Produced Complement Fragments C5a and C3a Provide Both Costimulatory and Survival Signals to Naive CD4+ T Cells

(2008) Michael G. Strainic et al.   IMMUNITY

Complement 5a Receptor Inhibition Improves Renal Allograft Survival

(2008) F. Gueler et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY